Taken together, our study reveals an essential role of the HOXC-AS3/YBX1/HOXC8 axis in NSCLC progression, shedding light on the molecular mechanisms of the disease and providing avenues for the development of therapeutic strategies. This evidence concerns the gene YBX1 and non-small cell lung carcinoma.